Clinical evaluation of MK-185: a new hypolipidemic drug

Lipids. 1972 Feb;7(2):96-9. doi: 10.1007/BF02532594.
No abstract available

Publication types

  • Clinical Trial
  • Controlled Clinical Trial

MeSH terms

  • Acetamides / blood
  • Acetamides / therapeutic use
  • Adult
  • Blood Protein Disorders / drug therapy*
  • Blood Proteins
  • Cholesterol / blood
  • Chromatography, Gas
  • Clinical Trials as Topic
  • Electrophoresis
  • Female
  • Fluorine / blood
  • Fluorine / therapeutic use
  • Glycolates / blood
  • Glycolates / therapeutic use*
  • Humans
  • Hypercholesterolemia / drug therapy*
  • Hypolipidemic Agents / therapeutic use*
  • Iodine / blood
  • Lipoproteins / blood*
  • Male
  • Middle Aged
  • Placebos
  • Protein Binding
  • Triglycerides / blood
  • Uric Acid / blood

Substances

  • Acetamides
  • Blood Proteins
  • Glycolates
  • Hypolipidemic Agents
  • Lipoproteins
  • Placebos
  • Triglycerides
  • Uric Acid
  • Fluorine
  • Iodine
  • Cholesterol